Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-seryl-proline and Graft Occlusion, Vascular

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Graft Occlusion, Vascular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MQ; Feng, XY; Guo, W; Jia, G; Li, J; Li, W; Li, Y; Song, LQ; Wang, H; Yu, J; Zhang, YM1

Trials

1 trial(s) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Graft Occlusion, Vascular

ArticleYear
Low strength static magnetic field inhibits the proliferation, migration, and adhesion of human vascular smooth muscle cells in a restenosis model through mediating integrins β1-FAK, Ca2+ signaling pathway.
    Annals of biomedical engineering, 2012, Volume: 40, Issue:12

    Topics: Cell Adhesion; Cell Movement; Cell Proliferation; Focal Adhesion Kinase 1; Graft Occlusion, Vascular; Humans; Integrins; Magnetic Fields; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oligopeptides; Phosphorylation; Umbilical Arteries

2012